Photos from Martine Deprez's post
To mark Pink October, the international breast cancer awareness month, the Ministry of Health and Social Security and the Health Directorate are launching a new campaign to highlight the importance of organised screening.
In July 2026, the Pharmacovigilance Risk Assessment Committee (PRAC) recommended adding the risk of meningioma to the package leaflet and to the summary of product characteristics (SmPC) of contraceptives containing desogestrel and etonogestrel.
Photos from Martine Deprez's post
Last update